http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2017170986-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5058 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0793 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00 |
| filingDate | 2017-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2017170986-A1 |
| titleOfInvention | Accumulation inducer of insolubilized TDP-43 protein, method for producing neurodegenerative disease model cell, and method for screening therapeutic or preventive agent for neurodegenerative disease |
| abstract | It is an object of the present invention to provide a method for producing a neurodegenerative disease model cell that does not depend on the introduction of a gene mutation and that can uniformly reproduce the pathology in the nerve cell of a disease patient, and a screening method using the model cell. It is said. The present invention relates to a method for producing a neurodegenerative disease model cell using an accumulation inducer of insolubilized TDP-43 protein having an inhibitory action on vitamin B1 uptake, and a screening for therapeutic or preventive agent for neurodegenerative disease using the model cell. Provide a method. |
| priorityDate | 2016-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 79.